Prediction and prevention of recurrent preeclampsia.

Prediction and prevention of recurrent preeclampsia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Prediction and prevention of recurrent preeclampsia. Abstract Text:

Women with a history of previous preeclampsia are at increased risk of preeclampsia and other adverse pregnancy outcomes in subsequent pregnancies. The magnitude of this risk is dependent on gestational age at time of disease onset, severity of disease, and presence or absence of preexisting medical disorders. The objective in the management of these patients is to reduce risk factors by optimizing maternal health before conception and to detect obstetric complications as early as possible. This objective can be achieved by formulating a rational approach that includes preconception evaluation and counseling, early antenatal care, frequent monitoring of maternal and fetal well-being, and timely delivery. First-trimester ultrasound examination is essential for accurate dating and establishing fetal number. Laboratory studies are obtained to assess the function of different organ systems that are likely to be affected by preeclampsia and to establish a baseline for future assessment. Recent studies have confirmed that there is no single biomarker that can be clinically useful for the prediction of recurrent preeclampsia. Combinations of biomarkers and biophysical parameters appear promising, but more data are needed to confirm their use in clinical practice. Supplementation with fish oil, calcium, or vitamin C and E and the use of antihypertensives have been shown to be ineffective in the prevention of recurrent preeclampsia and are not recommended. Supplementation with low-dose aspirin may be offered on an individualized basis. Because women with previous preeclampsia are at increased risk for adverse pregnancy outcomes (preterm delivery, fetal growth restriction, abruptio placentae, and fetal death) in subsequent pregnancies, we recommend more frequent monitoring for signs and symptoms of severe hypertension or preeclampsia than that recommended for normal pregnancy. This monitoring may include more frequent prenatal visits, home blood pressure monitoring, or nursing contacts. For patients with a prior pregnancy complicated by preeclampsia with fetal growth restriction, we recommend serial ultrasound evaluation of fetal growth and amniotic fluid volume. The development of severe gestational hypertension, fetal growth restriction, or recurrent preeclampsia requires maternal hospitalization.

Prediction and prevention of recurrent preeclampsia. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Prediction and prevention of recurrent preeclampsia. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Obstetrics and gynecology

VOLUME: 112

Page Numbers: 359-72

Journal Abbreviation:

ISSN: 0029-7844

DAY: 1

MONTH: Aug

YEAR: 2008

Prediction and prevention of recurrent preeclampsia. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 401101

Prediction and prevention of recurrent preeclampsia. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Prediction and prevention of recurrent preeclampsia. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Prediction and prevention of recurrent preeclampsia.

AFFILIATION: Division of Maternal-Fetal Medicine, Central Baptist Hospital, Lexington, Kentucky; and the Divison of Maternal-Fetal Medicine, University of Cincinnati, Cincinnati, Ohio.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Obstet Gynecol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Prediction and prevention of recurrent preeclampsia Related Publications

• Acute fatty liver of pregnancy.
• Antioxidant therapy to prevent preeclampsia: a randomized controlled trial.
• Chronic hypertension in pregnancy.
• Duodeno-jejunal junction: a histoanatomical study with the concept of the existence of an "anatomical" sphincter.
• Electromyographic lag time and opening time: two novel noninvasive methods to investigate patients with anal outlet obstruction and their response to treatment.
• Expectant management of severe preeclampsia at less than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management.
• HELLP syndrome: an atypical presentation.
• Hypertensive disorders of pregnancy: the United States perspective.
• Immediate post-operative vocal changes in patients using laryngeal mask airway versus endotracheal tube.
• Intergenerational factors: a missing link for preeclampsia, fetal growth restriction, and cardiovascular disease?
• Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation.
• Prediction and prevention of recurrent preeclampsia.
• Pregnancy outcome in isolated single umbilical artery.
• The coexistence of gestational hypertension and diabetes: influence on pregnancy outcome.
• The electromyographic activity of the external and internal urethral sphincters and urinary bladder on vaginal distension and its role in preventing vaginal soiling with urine during sexual intercourse.